作者: Tiansuo Zhao , Di Xiao , Fanjie Jin , Hongwei Wang , Jing Liu
DOI: 10.1101/2020.07.27.222455
关键词:
摘要: Pancreatic stellate cells (PSCs) play a pivotal role in pancreatic fibrosis and ductal adenocarcinoma (PDAC) progression. The mechanisms controlling PSC activation is not completely understood. Here we investigated the of ESE3 (Epithelium-Specific ETS factor 3) activation. We discovered that PDAC patients expression was increased while decreased tumor cells. overexpression promoted Condition medium from ESE3-overexprssing promotes cell migration, chemoresistance, growth fibrosis. directly induced transcription -SMA, Collagen 1 IL-1{beta} by binding to sites on their promoters activate PSC. On other hand, upregulates through NF{kappa}B required for derived IL-1{beta}. Clinical data showed upregulation positively correlated with size, pTNM stage, CA19-9, CEA CA242 level serum. an independent negative prognostic disease-free survival overall among patients. Inhibition IL-1{beta}/ (PSC)/ positive feedback loop represents promising therapeutic strategy reduce increase chemotherapeutic efficacy PDAC.